338 related articles for article (PubMed ID: 23176180)
1. Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.
Aguilar-Rojas A; Huerta-Reyes M; Maya-Núñez G; Arechavaleta-Velásco F; Conn PM; Ulloa-Aguirre A; Valdés J
BMC Cancer; 2012 Nov; 12():550. PubMed ID: 23176180
[TBL] [Abstract][Full Text] [Related]
2. Activation of human gonadotropin-releasing hormone receptor promotes down regulation of ARHGAP18 and regulates the cell invasion of MDA-MB-231 cells.
Aguilar-Rojas A; Maya-Núñez G; Huerta-Reyes M; Pérez-Solis MA; Silva-García R; Guillén N; Olivo-Marin JC
Mol Cell Endocrinol; 2018 Jan; 460():94-103. PubMed ID: 28709956
[TBL] [Abstract][Full Text] [Related]
3. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
Wu D; Asiedu M; Wei Q
Oncogene; 2009 Jun; 28(22):2219-30. PubMed ID: 19421144
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone receptor concentration differentially regulates intracellular signaling pathways in GGH3 cells.
Pinter JH; Janovick JA; Conn PM
Pituitary; 1999 Nov; 2(3):181-90. PubMed ID: 11081152
[TBL] [Abstract][Full Text] [Related]
5. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
Gründker C; Bauerschmitz G; Schubert A; Emons G
Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
[TBL] [Abstract][Full Text] [Related]
6. Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity.
Brew CT; Aronchik I; Kosco K; McCammon J; Bjeldanes LF; Firestone GL
Int J Cancer; 2009 May; 124(10):2294-302. PubMed ID: 19173291
[TBL] [Abstract][Full Text] [Related]
7. Gab2 regulates cytoskeletal organization and migration of mammary epithelial cells by modulating RhoA activation.
Herrera Abreu MT; Hughes WE; Mele K; Lyons RJ; Rickwood D; Browne BC; Bennett HL; Vallotton P; Brummer T; Daly RJ
Mol Biol Cell; 2011 Jan; 22(1):105-16. PubMed ID: 21118992
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
Gründker C; Föst C; Fister S; Nolte N; Günthert AR; Emons G
Breast Cancer Res; 2010; 12(4):R49. PubMed ID: 20630060
[TBL] [Abstract][Full Text] [Related]
9. Failure to detect gonadotrophin-releasing hormone receptors in human benign and malignant breast tissue and in MCF-7 and MDA-MB-231 cancer cells.
Mullen P; Bramley T; Menzies G; Miller B
Eur J Cancer; 1993; 29A(2):248-52. PubMed ID: 8380699
[TBL] [Abstract][Full Text] [Related]
10. Plasma membrane expression of gonadotropin-releasing hormone receptors: regulation by peptide and nonpeptide antagonists.
Finch AR; Caunt CJ; Armstrong SP; McArdle CA
Mol Endocrinol; 2010 Feb; 24(2):423-35. PubMed ID: 20009083
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of gonadotropin-releasing hormone (GnRH) receptor gene by GnRH: involvement of multiple signal transduction pathways.
Lin X; Conn PM
Endocrinology; 1999 Jan; 140(1):358-64. PubMed ID: 9886846
[TBL] [Abstract][Full Text] [Related]
12. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2.
Wu HM; Wang HS; Huang HY; Lai CH; Lee CL; Soong YK; Leung PC
BMC Cancer; 2013 Jun; 13():300. PubMed ID: 23786715
[TBL] [Abstract][Full Text] [Related]
14. GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines.
Morgan K; Meyer C; Miller N; Sims AH; Cagnan I; Faratian D; Harrison DJ; Millar RP; Langdon SP
BMC Cancer; 2011 Nov; 11():476. PubMed ID: 22051164
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone receptor-mediated growth suppression of immortalized LbetaT2 gonadotrope and stable HEK293 cell lines.
Miles LE; Hanyaloglu AC; Dromey JR; Pfleger KD; Eidne KA
Endocrinology; 2004 Jan; 145(1):194-204. PubMed ID: 14551223
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone (GnRH) receptors of cattle aggregate on the surface of gonadotrophs and are increased by elevated GnRH concentrations.
Kadokawa H; Pandey K; Nahar A; Nakamura U; Rudolf FO
Anim Reprod Sci; 2014 Nov; 150(3-4):84-95. PubMed ID: 25301533
[TBL] [Abstract][Full Text] [Related]
17. Cytoskeletal reorganization dependence of signaling by the gonadotropin-releasing hormone receptor.
Davidson L; Pawson AJ; Millar RP; Maudsley S
J Biol Chem; 2004 Jan; 279(3):1980-93. PubMed ID: 14559894
[TBL] [Abstract][Full Text] [Related]
18. Lack of telopeptides in fibrillar collagen I promotes the invasion of a metastatic breast tumor cell line.
Demou ZN; Awad M; McKee T; Perentes JY; Wang X; Munn LL; Jain RK; Boucher Y
Cancer Res; 2005 Jul; 65(13):5674-82. PubMed ID: 15994941
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation of gonadotropin-releasing hormone (GnRH) receptor gene by GnRH and cyclic adenosine monophosphate.
Lin X; Conn PM
Endocrinology; 1998 Sep; 139(9):3896-902. PubMed ID: 9724045
[TBL] [Abstract][Full Text] [Related]
20. AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells.
Dorfleutner A; Stehlik C; Zhang J; Gallick GE; Flynn DC
J Cell Physiol; 2007 Dec; 213(3):740-9. PubMed ID: 17520695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
